Related Experiment Video
Updated: Feb 15, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Novel Miniature Membrane Active Lipopeptidomimetics against Planktonic and Biofilm Embedded Methicillin-Resistant
Seema Joshi1, Sana Mumtaz2, Jyotsna Singh2
1Antimicrobial Research Laboratory, School of Environmental Sciences, Jawaharlal Nehru University, New Delhi, 110067, India. joshi.seema25@gmail.com.
Abstract:
Escalating multidrug resistance and highly evolved virulence mechanisms have aggravated the clinical menace of methicillin-resistant Staphylococcus aureus (MRSA) infections. Towards development of economically viable staphylocidal agents here we report eight structurally novel tryptophan-arginine template based peptidomimetics. Out of the designed molecules, three lipopeptidomimetics (S-6, S-7 and S-8) containing 12-amino dodecanoic acid exhibited cell selectivity and good to potent activity against clinically relevant pathogens MRSA, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium (MIC: 1.4-22.7 μg/mL). Mechanistically, the active peptidomimetics dissipated membrane potential and caused massive permeabilization on MRSA concomitant with loss of viability. Against stationary phase MRSA under nutrient-depleted conditions, active peptidomimetics S-7 and S-8 achieved > 6 log reduction in viability upon 24 h incubation while both S-7 (at 226 μg/mL) and S-8 (at 28 μg/mL) also destroyed 48 h mature MRSA biofilm causing significant decrease in viability (p < 0.05). Encouragingly, most active peptidomimetic S-8 maintained efficacy against MRSA in presence of serum/plasma while exhibiting no increase in MIC over 17 serial passages at sub-MIC concentrations implying resistance development to be less likely. Therefore, we envisage that the current template warrants further optimization towards the development of cell selective peptidomimetics for the treatment of device associated MRSA infections.
Insights
Novel peptidomimetics show potent activity against drug-resistant bacteria like methicillin-resistant Staphylococcus aureus (MRSA). These compounds disrupt bacterial membranes and effectively reduce MRSA viability and biofilms, offering a promising avenue for new antimicrobial therapies.
Area of Science:
- Medicinal Chemistry
- Microbiology
- Antimicrobial Resistance
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant clinical challenge due to multidrug resistance and virulence.
- Existing treatments are increasingly ineffective against evolving strains of MRSA.
Purpose of the Study:
- To design and synthesize novel tryptophan-arginine template-based peptidomimetics.
- To evaluate the antimicrobial activity and mechanism of action of these compounds against clinically relevant pathogens, including MRSA.
Main Methods:
- Synthesis of eight novel peptidomimetics based on a tryptophan-arginine template.
- Antimicrobial susceptibility testing (MIC) against MRSA, methicillin-resistant Staphylococcus epidermidis, and vancomycin-resistant Enterococcus faecium.
- Assessment of membrane potential dissipation and permeabilization in MRSA.
- Evaluation of activity against stationary-phase MRSA and mature MRSA biofilms.
- In vitro stability testing in serum/plasma and assessment of resistance development potential.
Main Results:
- Three lipopeptidomimetics (S-6, S-7, S-8) demonstrated potent activity (MIC: 1.4-22.7 μg/mL) against MRSA, MRSE, and VRE.
- Active compounds dissipated membrane potential and caused MRSA membrane permeabilization, leading to loss of viability.
- S-7 and S-8 significantly reduced viability of stationary-phase MRSA and destroyed mature MRSA biofilms.
- S-8 maintained efficacy in serum/plasma and showed no resistance development over 17 serial passages.
Conclusions:
- Novel tryptophan-arginine peptidomimetics exhibit promising broad-spectrum antimicrobial activity against challenging pathogens.
- The compounds act by disrupting bacterial membrane integrity.
- The developed peptidomimetics, particularly S-8, show potential for treating device-associated MRSA infections with low likelihood of resistance development.
More Related Videos
Related Concept Videos
Biofilms
Resistivity
Resistance
Primary Active Transport
Equivalent Resistance
Resistance and Conductance
Various factors impact the resistance of a conductor. Spiraling in stranded conductors increases their...

